CPHI Milan 2026
10/2026 – 10/2026
Über das Unternehmen
- Firmenname (rechtlich): Dongkook Pharmaceutical Co., Ltd.
- Registrierungsland: Republic of Korea
- Adresse: 715, Yeongdong-daero,, Gangnam-gu, Seoul
- Anzahl der Mitarbeiter: 1000 - 4999
Beschreibung:
Founded in 1968, Dongkook Pharmaceutical has concentrated on R&D and technology innovation, becoming well known for high-brand-value OTC products in Korea, alongside developing and producing therapeutic products including anesthetics, contrast media and anti-cancer agents. The company is recognized by domestic and foreign authorities for the quality of its finished products, medical devices and APIs, and currently exports finished products, medical devices and APIs internationally.
Geschäftsaktivitäten
Vertrags- & Outsourcing-Dienstleistungen
Hersteller
Fertigarzneiformen
Hersteller
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
Hersteller
Original-Wirkstoffe
Hersteller
Hauptprodukte/-dienstleistungen
- Vertrags- & Outsourcing-Dienstleistungen: Teicoplanin
- Fertigarzneiformen: Donepezil Depot Injection
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Liposomal Amphotericn B Injection, Leuprolide Acetate Injection, Leuprolide Acetate Depot Injection, Propofol Injection, Dexmedetomidine Hydrochloride Injection, Octreotide Acetate LAR Injection
Unsere Produkte & Dienstleistungen
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Proofs
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen